XML 40 R28.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 1 - Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 15, 2014
Oct. 29, 2014
Feb. 15, 2011
Nov. 27, 2016
Aug. 28, 2016
Nov. 27, 2016
Nov. 29, 2015
[1]
May 29, 2016
May 30, 2016
Number of Proprietary Platforms       2   2      
Debt Issuance Costs, Current, Net       $ 60,000   $ 60,000      
Debt Issuance Costs, Noncurrent, Net       229,000   229,000      
Loss Contingency, Loss in Period       $ 500,000          
Loss Contingency Per Diluted Share       $ 0.01          
Payments of Debt Extinguishment Costs       $ 233,000   233,000    
Cumulative Effect of New Accounting Principle in Period of Adoption [2]       623,000   623,000      
Reclassification of Debt Issuance Costs from Assets to Reduction in Liabilities [Member] | May 29, 2016 [Member]                  
Prior Period Reclassification Adjustment         $ 817,000        
Reclassification of Debt Issuance Costs from Other Current Assets to Reduction in Current Portion of Long-term Debt [Member] | May 29, 2016 [Member]                  
Prior Period Reclassification Adjustment         175,000        
Reclassification of Debt Issuance Costs from Other Noncurrent Assets to Reduction in Long-term Debt [Member] | May 29, 2016 [Member]                  
Prior Period Reclassification Adjustment         $ 642,000        
Reclassifiction of Stock-based Compensation Excess Tax Benefits from Financing Activities to Operating Activities [Member] | Six Months Ended November 29th, 2015 [Member]                  
Prior Period Reclassification Adjustment           $ 90,000      
Sales Revenue, Goods, Net [Member] | Product Concentration Risk [Member] | Ophthalmic [Member] | HA Based Biomaterials [Member]                  
Concentration Risk, Percentage               55.00%  
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | Orthopedic [Member] | HA Based Biomaterials [Member]                  
Concentration Risk, Percentage               20.00%  
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | Other/Non-HA [Member] | HA Based Biomaterials [Member]                  
Concentration Risk, Percentage               25.00%  
Customer Relationships [Member] | Minimum [Member]                  
Finite-Lived Intangible Asset, Useful Life           12 years      
Customer Relationships [Member] | Maximum [Member]                  
Finite-Lived Intangible Asset, Useful Life           13 years      
Retained Earnings [Member]                  
Cumulative Effect of New Accounting Principle in Period of Adoption [2]       423,000   $ 423,000      
Retained Earnings [Member] | Adjustment for Unrecoganized Excess Tax Benefits [Member]                  
Cumulative Effect of New Accounting Principle in Period of Adoption                 $ 549,000
Retained Earnings [Member] | Adjustment for Forfeitures Treatment [Member]                  
Cumulative Effect of New Accounting Principle in Period of Adoption                 (126,000)
Additional Paid-in Capital [Member]                  
Cumulative Effect of New Accounting Principle in Period of Adoption [2]       $ 200,000   $ 200,000      
Additional Paid-in Capital [Member] | Adjustment for Forfeitures Treatment [Member]                  
Cumulative Effect of New Accounting Principle in Period of Adoption                 200,000
Windset [Member]                  
Investment Ownership Percentage 26.90%                
Apio [Member] | Windset [Member]                  
Payments to Acquire Investments $ 11,000,000                
Investment Ownership Percentage       60.00%   60.00%      
Apio [Member] | Windset [Member] | Common Stock [Member]                  
Investment In Non Public Company Shares 68   201            
Payments to Acquire Investments     $ 201            
Apio [Member] | Windset [Member] | Senior B Preferred Stock [Member]                  
Investment In Non Public Company Shares   70,000 150,000            
Payments to Acquire Investments   $ 7,000,000 $ 15,000,000            
Apio [Member] | Windset [Member] | Junior Preferred Shares [Member]                  
Investment In Non Public Company Shares 51,211                
Payments to Acquire Investments $ 11,000,000                
Prepaid Expenses and Other Current Assets [Member]                  
Debt Issuance Costs, Gross       $ 120,000   $ 120,000      
Other Assets [Member]                  
Debt Issuance Costs, Gross       $ 459,000   $ 459,000      
Deferred Taxes [Member] | Adjustment for Forfeitures Treatment [Member]                  
Cumulative Effect of New Accounting Principle in Period of Adoption                 $ (74,000)
[1] See Note 1 - Organization, Basis of Presentation, and Summary of Significant Accounting Policies for a discussion of accounting principles adopted during the period.
[2] See Note 1 - Organization, Basis of Presentation, and Summary of Significant Accounting Policies for a discussion of accounting guidance adopted during the period.